| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 11 | +63.64% | -1.39% | +0.39% | -1.78% | -3.83% | — |
| 14d | 11 | +72.73% | -8.38% | -1.46% | -6.92% | -7.76% | — |
| 30d | 11 | +72.73% | -7.54% | -1.52% | -6.02% | -7.48% | — |
| 60d | 11 | +45.45% | -3.43% | +0.51% | -3.94% | +3.22% | — |
| 90d | 11 | +54.55% | -0.19% | +1.25% | -3.07% | -0.17% | — |
| 180d | 11(3 pending) | +75.00% | -10.75% | +2.31% | -13.05% | -35.01% | — |
| 1y | 11(5 pending) | +66.67% | -26.45% | +16.32% | -42.77% | -50.19% | — |
| 2y | 11(11 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| VIR VIR BIOTECHNOLOGY, INC. | SALE10b5-1 10b5-1 plan | 13,700 | $9.82 | $134.5K | 112,982 | Feb 25, 2026 | Feb 26, 2026 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE10b5-1 10b5-1 plan | 3,117 | $9.53 | $29.7K | 126,682 | Feb 24, 2026 | Feb 26, 2026 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE10b5-1 10b5-1 plan | 4,445 | $7.45 | $33.1K | 129,799 | Feb 23, 2026 | Feb 24, 2026 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASEGRANT Stock grant | 110,000 | — | — | 110,000 | Feb 22, 2026 | Feb 24, 2026 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASEGRANT Stock grant | 55,000 | — | — | 134,244 | Feb 22, 2026 | Feb 24, 2026 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE10b5-1 10b5-1 plan | 2,385 | $5.16 | $12.3K | 78,210 | Nov 5, 2025 | Nov 7, 2025 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE10b5-1 10b5-1 plan | 1,365 | $5.86 | $8.0K | 80,595 | Nov 3, 2025 | Nov 4, 2025 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE10b5-1 10b5-1 plan | 7,373 | $9.14 | $67.4K | 79,460 | Feb 26, 2025 | Feb 27, 2025 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE10b5-1 10b5-1 plan | 5,140 | $9.45 | $48.6K | 86,833 | Feb 24, 2025 | Feb 25, 2025 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASEGRANT Stock grant | 35,000 | — | — | 91,973 | Feb 22, 2025 | Feb 25, 2025 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASEGRANT Stock grant | 70,000 | — | — | 70,000 | Feb 22, 2025 | Feb 25, 2025 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE EVP and General Counsel | 76 | $8.22 | $625 | 56,973 | Dec 2, 2024 | Dec 4, 2024 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE10b5-1 10b5-1 plan | 4,397 | $10.11 | $44.5K | 56,973 | Nov 6, 2024 | Nov 7, 2024 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE10b5-1 10b5-1 plan | 2,347 | $9.47 | $22.2K | 61,370 | Nov 5, 2024 | Nov 5, 2024 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE10b5-1 10b5-1 plan | 1,403 | $7.20 | $10.1K | 63,717 | Nov 1, 2024 | Nov 5, 2024 ↗ | View → |